Effectiveness of Direct-Acting Antivirals in Treatment of Elderly Egyptian Chronic Hepatitis C Patients
Background: Hepatitis C virus treatment has dramatically improved by direct-acting antiviral (DAA) therapy. The aim of this study was to assess the efficacy and safety of DAA in elderly Egyptian chronic hepatitis C (CHC) patients. Methods: The study was carried out on 327 CHC elderly patients >60...
Main Authors: | Shimaa Kamel, Hagar Elessawy, Ossama Ashraf, Ahmed Elbaz, Hany Dabbous, Manal El-Sayed, Safaa Ali, Heba Kamel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Gastroenterology Insights |
Subjects: | |
Online Access: | https://www.mdpi.com/2036-7422/12/3/31 |
Similar Items
-
Efficacy of Combination Sofosbuvir, Pegylated-Interferon, and Ribavirin for Treatment of Hepatitis C Virus Genotype 1 Infection in Indonesia
by: Andri Sanityoso Sulaiman, et al.
Published: (2018-08-01) -
Hepatitis C direct‐acting antiviral outcomes in patients 75 years and older
by: Parmvir Parmar, et al.
Published: (2021-02-01) -
THE EVOLUTION OF LIVER FIBROSIS AFTER THE TREATMENT WITH DIRECT-ACTING ANTIVIRAL AGENTS IN HEPATIC CIRRHOSIS: EXPERIENCE OF A CENTER
by: Mariana Avricenco, et al.
Published: (2020-10-01) -
High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C
by: Andrew Hill, et al.
Published: (2017-10-01) -
Very rapid virologic response and early HCV response kinetics, as quick measures to compare efficacy and guide a personalized response-guided therapy
by: Yakoot M, et al.
Published: (2016-08-01)